drugset / Trial / NCT07760246
A Study in Healthy People to Measure How Different Doses of Verducatib Affect the Heart
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The main objective of this trial is to evaluate the effects of verducatib in the range of therapeutic to supra-therapeutic exposures on the QT/QTc-interval and other ECG parameters
Timeline
- Start
- 2026-08-20
- Primary completion
- 2026-12-16
- Completion
- 2026-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moxifloxacin | Small molecule | — | — |
| Subject | Verducatib | Unknown | — | — |
Indications
No indication recorded.